- DKK20.84bn
- DKK20.71bn
- DKK6.04bn
Europe Research Roundup: Pollen Street, Redrow, Taylor Wimpey
Ambu falls to the bottom of STOXX on 'cautious' outlook
Brief: Ambu Q4 EBIT Before Items Loss DKK 7 Million, In Line With Expectations
Danish life science cos to enjoy 'USD bonanza' in 2023 - Nordnet
Brief: Ambu CEO Buys 41,333 Shares
Ambu's shares rise post no-surprise report implies investors' hope for future, analyst says
Brief: Ambu Q3 EBIT Before Special Items In Line With Prelim DKK 42 Million
Ambu plummets after guidance and job cuts
Brief: Ambu A/S Says Cost Reduction Program Will Correspond To A Reduction Of Approximately 200 Employees From Global Workforce; Revises FY Guidance
Brief: Ambu Receives FDA Clearance For 5th Generation Single-Use Bronchoscope
'Better late than never' CEO change fuels Ambu shares
Ambu shares jump on new CEO appointment
Brief: Ambu Appoints Britt Meelby Jensen As New CEO
Ambu hits bottom of STOXX amid rating/TP cuts, poor sentiment
European shares suffer worst week in 2 months; tech, retail fall (updated)
Ambu shares slump after yet another guidance cut
Brief: Ambu Says Revenue For Q2 Was DKK 1,122M
Carnegie cuts estimates, but ups Ambu due to price drop
Brief: Ambu Announces Thomas Schmidt As New CFO